Total Payments
$4,158
2024 Payments
$555.05
Companies
32
Transactions
186
Medicare Patients
4,603
Medicare Billing
$572,219
Payment Breakdown by Category
Food & Beverage$4,158 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,158 | 186 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $535.17 | 21 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $522.52 | 22 | $0 (2024) |
| PFIZER INC. | $483.62 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $326.17 | 15 | $0 (2024) |
| Novo Nordisk Inc | $321.42 | 17 | $0 (2024) |
| Lilly USA, LLC | $231.06 | 12 | $0 (2024) |
| Amgen Inc. | $208.74 | 7 | $0 (2024) |
| AbbVie Inc. | $186.01 | 9 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $140.12 | 7 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $137.57 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $555.05 | 21 | AstraZeneca Pharmaceuticals LP ($106.53) |
| 2023 | $858.48 | 32 | GlaxoSmithKline, LLC. ($212.86) |
| 2022 | $636.86 | 25 | PFIZER INC. ($93.83) |
| 2021 | $623.94 | 27 | PFIZER INC. ($93.02) |
| 2020 | $538.31 | 24 | PFIZER INC. ($93.16) |
| 2019 | $565.24 | 30 | Boehringer Ingelheim Pharmaceuticals, Inc. ($75.90) |
| 2018 | $350.91 | 25 | Takeda Pharmaceuticals U.S.A., Inc. ($74.44) |
| 2017 | $29.27 | 2 | GlaxoSmithKline, LLC. ($16.25) |
All Payment Transactions
186 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $33.63 | General |
| Category: VACCINES | ||||||
| 12/23/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $40.84 | General |
| Category: Endocrinology | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: UROLOGY | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: VACCINES | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: DIABETES | ||||||
| 08/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: RESPIRATORY | ||||||
| 06/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Diabetes | ||||||
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Respiratory | ||||||
| 05/14/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $35.98 | General |
| Category: VACCINES | ||||||
| 04/01/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: Cardiology | ||||||
| 03/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Diabetes | ||||||
| 03/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: DIABETES | ||||||
| 02/26/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: Endocrinology | ||||||
| 02/12/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: VACCINES | ||||||
| 02/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $29.57 | General |
| Category: Respiratory | ||||||
| 01/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Diabetes | ||||||
| 11/21/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $31.52 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,229 | 1,835 | $528,830 | $160,601 |
| 2022 | 18 | 1,221 | 1,832 | $466,395 | $147,249 |
| 2021 | 17 | 1,146 | 1,725 | $470,415 | $152,288 |
| 2020 | 14 | 1,007 | 1,528 | $428,735 | $112,080 |
Total Patients
4,603
Total Services
6,920
Medicare Billing
$572,219
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 188 | 590 | $197,050 | $57,368 | 29.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 177 | 177 | $70,385 | $27,577 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 144 | 318 | $81,750 | $21,103 | 25.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 107 | 108 | $36,580 | $10,159 | 27.8% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 68 | 69 | $24,150 | $8,865 | 36.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 23 | 23 | $11,315 | $6,204 | 54.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 80 | 80 | $21,725 | $6,065 | 27.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 140 | 141 | $20,970 | $5,199 | 24.8% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 83 | 84 | $11,340 | $4,159 | 36.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 20 | 24 | $12,250 | $3,822 | 31.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 46 | 46 | $11,500 | $3,237 | 28.1% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 15 | 15 | $5,250 | $2,145 | 40.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 24 | 30 | $8,150 | $1,547 | 19.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 23 | 23 | $3,000 | $854.22 | 28.5% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 16 | 17 | $2,040 | $841.84 | 41.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 37 | 37 | $3,595 | $833.62 | 23.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 26 | 30 | $5,710 | $326.83 | 5.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 23 | $2,070 | $295.89 | 14.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 204 | 664 | $215,800 | $62,082 | 28.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 180 | 180 | $69,300 | $28,121 | 40.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 131 | 260 | $65,000 | $18,367 | 28.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 93 | 93 | $20,460 | $6,463 | 31.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 158 | 158 | $15,880 | $5,766 | 36.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 18 | 19 | $12,920 | $4,107 | 31.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 43 | 43 | $13,975 | $4,007 | 28.7% |
About Dr. Gina Wang, MD
Dr. Gina Wang, MD is a Internal Medicine healthcare provider based in Oakland, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619991510.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gina Wang, MD has received a total of $4,158 in payments from pharmaceutical and medical device companies, with $555.05 received in 2024. These payments were reported across 186 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($4,158).
As a Medicare-enrolled provider, Wang has provided services to 4,603 Medicare beneficiaries, totaling 6,920 services with total Medicare billing of $572,219. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Oakland, CA
- Active Since 07/26/2006
- Last Updated 07/09/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1619991510
Products in Payments
- JARDIANCE (Drug) $319.53
- PREVNAR 20 (Biological) $202.27
- TRELEGY ELLIPTA (Drug) $176.40
- Ozempic (Drug) $166.74
- EVENITY (Biological) $157.48
- BREZTRI (Drug) $148.28
- AREXVY (Drug) $128.43
- SHINGRIX (Biological) $127.81
- Rybelsus (Drug) $120.12
- NUEDEXTA (Drug) $106.63
- STIOLTO RESPIMAT (Drug) $101.12
- Kerendia (Drug) $95.15
- SOLIQUA 100/33 (Biological) $95.02
- XARELTO (Drug) $92.64
- FARXIGA (Drug) $92.12
- Vascepa (Drug) $90.17
- EMGALITY (Drug) $76.94
- PREVNAR 13 (Biological) $70.69
- DUPIXENT (Biological) $68.69
- ELIQUIS (Drug) $68.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Oakland
Jeffrey Burack, M.d, M.D
Internal Medicine — Payments: $592,777
Internal Medicine $592,777
Stephanie Christenson, Md, MD
Internal Medicine — Payments: $424,755
Internal Medicine $424,755
Robert Hagar, M.d, M.D
Internal Medicine — Payments: $70,113
Internal Medicine $70,113
Min Yan, M.d, M.D
Internal Medicine — Payments: $45,508
Internal Medicine $45,508
Anita Chang, Md, MD
Internal Medicine — Payments: $27,813
Internal Medicine $27,813
Dr. Robert Bober, Md, MD
Internal Medicine — Payments: $26,112
Internal Medicine $26,112